دورية أكاديمية

Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women.

التفاصيل البيبلوغرافية
العنوان: Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women.
المؤلفون: Trocin KE; Battelle Memorial Institute (KET, NIW, EAG, VHC-C); Bureau of Primary Health Care/Office of Quality Improvement, Health Resources and Services Administration, Rockville, MD (KET); Center for Applied Public Health Research, RTI International, Rockville, MD (EAO); Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD (KSM, VHC-C); The Emmes Company, LLC, Rockville, MD (VHC-C)., Weinstein NI, Oga EA, Mark KS, Coleman-Cowger VH
المصدر: Journal of addiction medicine [J Addict Med] 2020 Mar/Apr; Vol. 14 (2), pp. 139-144.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101306759 Publication Model: Print Cited Medium: Internet ISSN: 1935-3227 (Electronic) Linking ISSN: 19320620 NLM ISO Abbreviation: J Addict Med Subsets: MEDLINE
أسماء مطبوعة: Publication: [Alphen aan den Rijn, the Netherlands] : Wolters Kluwer Health, Inc.
Original Publication: Hagerstown, MD : Lippincott Williams & Wilkins
مواضيع طبية MeSH: Attitude of Health Personnel* , Mass Screening* , Pregnant Women* , Prenatal Care*, Pregnancy Complications/*diagnosis , Substance-Related Disorders/*diagnosis, Female ; Humans ; Maryland ; Pregnancy
مستخلص: Objective: There is a need to identify an acceptable and comprehensive substance use screening tool for pregnant women in the United States. This qualitative study sought to better understand prenatal practice staff perceptions of three existing substance use screening tools for use among pregnant women in an outpatient practice setting.
Methods: Eight focus groups with 40 total participants were conducted with clinical and administrative staff of 2 diverse Maryland prenatal practices to determine the acceptability and usability of 3 substance use screening tools (4P's Plus, NIDA-Modified Alcohol, Smoking and Substance Involvement Screening Test, and the Substance Use Risk Profile-Pregnancy scale). The focus groups were digitally recorded, transcribed, coded, and analyzed using thematic analysis.
Results: Participant perceptions of screening tools were dependent upon screening tool length, tone, comprehensiveness, subjectivity, time frame of questions, and scoring and clinician instructions. Most participants preferred the 4P's Plus screening tool because it is brief, comprehensive, easy for the patient to understand, and excludes judgmental language and subjective questions.
Conclusions: These results provide valuable insight into the specific needs and preferences of prenatal practice staff as it relates to prenatal substance use screening and provides evidence that the 4P's Plus may be a preferred screening tool for standardized use in prenatal care.
References: Am J Obstet Gynecol. 2001 Mar;184(4):752-8. (PMID: 11262483)
Addiction. 2017 Jul;112(7):1123-1125. (PMID: 28247578)
Obstet Gynecol. 2017 Aug;130(2):e81-e94. (PMID: 28742676)
J Perinatol. 2005 Jun;25(6):368-74. (PMID: 15703775)
Addiction. 2008 Jun;103(6):1039-47. (PMID: 18373724)
Obstet Gynecol. 2010 Oct;116(4):827-833. (PMID: 20859145)
BMJ Open. 2018 Feb 17;8(2):e020248. (PMID: 29455170)
Harm Reduct J. 2004 Apr 20;1(1):5. (PMID: 15169566)
Obstet Gynecol. 2019 May;133(5):952-961. (PMID: 30969217)
J Addict Med. 2020 Sep/Oct;14(5):423-430. (PMID: 32032210)
Am J Health Promot. 2017 Jan;31(1):35-42. (PMID: 26559718)
معلومات مُعتمدة: R01 DA041328 United States DA NIDA NIH HHS
تواريخ الأحداث: Date Created: 20190516 Date Completed: 20210616 Latest Revision: 20221005
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC6842409
DOI: 10.1097/ADM.0000000000000543
PMID: 31090554
قاعدة البيانات: MEDLINE
الوصف
تدمد:1935-3227
DOI:10.1097/ADM.0000000000000543